Acceleron Pharma Inc.
Methods for increasing red blood cell levels and treating ineffective erythropoiesis

Last updated:

Abstract:

In certain aspects, the present disclosure provides compositions and methods for increasing red blood cell and/or hemoglobin levels in a subject in need thereof. Subjects in need include, for example, subjects having anemia and/or ineffective erythropoiesis as a result of having reduced GATA-1, heat shock factor and/or NFE2 levels as compared to the levels in a reference population.

Status:
Grant
Type:

Utility

Filling date:

4 Nov 2016

Issue date:

21 Sep 2021